TYRA

TYRA

USD

Tyra Biosciences Inc. Common Stock

$15.000-0.210 (-1.381%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$15.210

Kõrge

$15.720

Madal

$14.540

Maht

0.09M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

799.5M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.22M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $6.42Praegune $15.000Kõrge $17.78

Seotud uudised

Analyst Upgrades

Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35

Raymond James analyst Chris Raymond initiates coverage on Tyra Biosciences with a Strong Buy rating and announces Price Target of $35.

Vaata rohkem
Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences with a Buy and maintains $30 price target.

Vaata rohkem
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target
PR Newswire

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

Vaata rohkem
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
PR Newswire

Tyra Biosciences Announces Participation at Upcoming Investor Events

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

Vaata rohkem
Tyra Biosciences Announces Participation at Upcoming Investor Events

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.